Registered entities
INCANTHERA PLC
Reg. No. 11026926Germany
INCANTHERA ONCOLOGY LIMITED
Reg. No. 7596505United Kingdom
Innovation
5 patent families (3 granted) — focus: Human necessities; filing pace slowing. Cited 513 times.
| Year | Filings |
|---|---|
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 1 |
| 2022 | 1 |
Social engagement
Social engagement: 96 social following, 8 posts in the last 12 months — top quartile of its industry.
Investor mix
8 investors on record; lead investors include University of Bradford; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 13% |
| Private equity | 2 | 25% |
| Angel & family office | 1 | 13% |
| Bank & private debt | 1 | 13% |
| Other / undisclosed | 3 | 38% |
Recent activity
22 Nov 2025
Product launch
Skin+CELL
18 Nov 2025
Event
Aquis Stock Exchange 4th Aquis Showcase
14 Nov 2025
Event
Aquis Stock Exchange 4th Aquis Showcase